Stock Price
7.95
Daily Change
-0.05 -0.63%
Monthly
-3.05%
Yearly
26.19%
Q3 Forecast
7.94

Malin Corporation reported EUR3.8M in Gross Profit on Sales for its fiscal semester ending in December of 2020.


Gross Profit On Sales Change Date
Alaunos Therapeutics -1127000 1.11M Sep/2024
ALKERMES USD 257.77M 462K Jun/2025
Avita Medical AUD 16.13M 3.05M Dec/2024
Dianthus Therapeutics 193K 970K Jun/2025
Eurofins Scientific SE EUR 795.6M 39M Dec/2024
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Lonza CHF 1.04B 72M Dec/2024
Malin Corporation EUR 3.8M 2.6M Dec/2020
Moderna USD 18M 1000K Jun/2025
Organon & Co USD 874M 33M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Tectonic Therapeutic 0 0 Mar/2025
Viatris USD 1.33B 98.1M Jun/2025
Xeris Pharmaceuticals USD 59.64M 9.02M Jun/2025